 Connection
Stephen Daniels to Drug Administration Schedule
This is a "connection" page, showing publications Stephen Daniels has written about Drug Administration Schedule.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.168 |
|
|
|
-
Daniels S, Gitton X, Zhou W, Stricker K, Barton S. Efficacy and tolerability of lumiracoxib 200 mg once daily for treatment of primary dysmenorrhea: results from two randomized controlled trials. J Womens Health (Larchmt). 2008 Apr; 17(3):423-37.
Score: 0.062
-
Christensen S, Paluch E, Jayawardena S, Daniels S, Meeves S. Analgesic Efficacy of a New Immediate-Release/Extended-Release Formulation of Ibuprofen: Results From Single- and Multiple-Dose Postsurgical Dental Pain Studies. Clin Pharmacol Drug Dev. 2017 May; 6(3):302-312.
Score: 0.028
-
Harii K, Arase S, Tsuboi R, Weng E, Daniels S, VanDenburgh A. Bimatoprost for eyelash growth in Japanese subjects: two multicenter controlled studies. Aesthetic Plast Surg. 2014 Apr; 38(2):451-60.
Score: 0.023
-
Altman R, Daniels S, Young CL. Indomethacin submicron particle capsules provide effective pain relief in patients with acute pain: a phase 3 study. Phys Sportsmed. 2013 Nov; 41(4):7-15.
Score: 0.023
-
Manvelian G, Daniels S, Gibofsky A. The pharmacokinetic parameters of a single dose of a novel nano-formulated, lower-dose oral diclofenac. Postgrad Med. 2012 Jan; 124(1):117-23.
Score: 0.020
-
Flynn JT, Newburger JW, Daniels SR, Sanders SP, Portman RJ, Hogg RJ, Saul JP. A randomized, placebo-controlled trial of amlodipine in children with hypertension. J Pediatr. 2004 Sep; 145(3):353-9.
Score: 0.012
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|